Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art

RSS



app icon

iPhone

app store icon

Kindle



Orthopedic and Dental Industry News

October 2008

Alphatec Spine Expands European Presence; Names Peter Kohlbecher as Vice President, General Manager - Europe BY EDITOR, OCTOBER 31, 2008

Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine,... more

Musculoskeletal News Roundup 30-Oct-08 BY LAUREN UZDIENSKI, OCTOBER 30, 2008

Earnings Exactech reported 3Q:08 revenues of $37.9 million, missing revenues by $0.9 million and representing an increase of 27% over the year-ago period. Among segments, knee revenue increased 16%; organic hip implant revenue increased 8%; biologic services revenue increased 12%;... more

Alphatec Spine Appoints Siri S. Marshall, Esq. to Its Board of Directors BY EDITOR, OCTOBER 29, 2008

Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced... more

BioMimetics' Experience A Microcosm of Current Credit Crisis within Ortho BY DAVID KRESSEL, OCTOBER 27, 2008

This evening, BioMimetic Therapeutics (BMTI) issued a press release stating it has reached a settlement with Deutsche Bank regarding BMTI's holdings of auction-rate securities (ARS). BMTI told investors on its 2Q08 conference call that it had approximately $60 million of... more

New York Times Questions the Safety, Efficacy of 510(k)s BY LAUREN UZDIENSKI, OCTOBER 27, 2008

The New York Times has joined a chorus of concern over the 510(k) process, suggesting in an article yesterday that 510(k)s are outdated (FDA device laws were passed "when devices played a much smaller role in medicine") and allow new... more

The High Yield Canary in the Coalmine? BY JOHN MCCORMICK, OCTOBER 24, 2008

Last week global equities were up on points of light in the interbank lending markets and this week equities have been pricing in a recession. Another important market is also pricing in a recession: high yield bonds. Before we get... more

Musculoskeletal News Roundup 22-Oct-08 BY LAUREN UZDIENSKI, OCTOBER 22, 2008

Earnings CONMED reported 3Q:08 revenues of $179.4 million, up 9% over the year-ago period and beating estimates by $2.95 million. Arthroscopy was up 18% (17% constant currency), contributing $69.5 million to total sales. On a non-GAAP basis, diluted earnings per... more

NASS Compendium: Industry Showcases the Latest in Spine BY LAUREN UZDIENSKI, OCTOBER 21, 2008

Last week we attended NASS in Toronto, where we saw the launch of a number of new products as well as the release of new clinical data and the first wave of 3Q:08 earnings results. M&A M&A news was quiet... more

A Thaw in the Credit Markets? BY JOHN MCCORMICK, OCTOBER 20, 2008

Global equity markets have breathed a collective sigh of relief last week thanks to the U.S. Treasury announcing it is recapitalizing banks and the prospect of a thaw in credit markets. Our latest observations are below. U.S. Treasury Update The... more

ISTO's NuQu Shows Promise for Cartilage Regneration BY LAUREN UZDIENSKI, OCTOBER 17, 2008

At NASS this week, ISTO Technologies announced promising data from an animal study evaluating their NuQu cell therapy for the treatment of degenerative disc disease. NuQu is a non-invasive cell therapy derived from juvenile chondrocytes and delivered with a protein... more

Musculoskeletal News Roundup 16-Oct-08 BY LAUREN UZDIENSKI, OCTOBER 16, 2008

Earnings Biomet reported FQ1:09 revenues of $607.0 million, up 13% (9% constant currency) over the year-ago period. Excluding special charges, adjusted operating income was $171.6 million for FQ1:09, up 12% over FQ1:08. Among segments, reconstructive reported $449.3 million in sales,... more

Alphatec Spine Launches www.agingspinecenter.com -- Web-Based Portal for Healthcare Providers and Patients BY EDITOR, OCTOBER 14, 2008

Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions affecting the aging spine,... more

Musculoskeletal News Roundup 9-Oct-08 BY LAUREN UZDIENSKI, OCTOBER 9, 2008

M&A Life Spine, Inc. has acquired the "majority" of the intellectual property of Spinal Generations, LLC. Neither details on the acquired technology nor terms of the transaction were disclosed. Funding Harvard received a $125 million donation from Synthes Chairman Hansjorg... more

Little Known FDA Clearance Path Gains Steam BY ELOISE AUSTIN, OCTOBER 9, 2008

The FDA "de novo" classification pathway is an often overlooked but potentially valuable regulatory clearance process for device manufacturers. The pathway involves a streamlined reclassification process for devices that are low-risk but have no sufficiently equivalent (NSE) predicate (i.e. have... more

Robin Young and John McCormick Discuss / Debate Credit Markets BY EDITOR, OCTOBER 8, 2008

This article first appeared in the October 7, 2008 edition of Orthopedics This Week. Robin: John, first of all, thank you so much for agreeing to discuss this unprecedented crisis in the capital markets. From my perspective, this is an... more

Alphatec Spine Launches New Orthobiologics Product - ProFUSE Bone Scaffold Packaged in Proprietary Vacuum Infusion Packaging System BY EDITOR, OCTOBER 7, 2008

Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions affecting the aging spine,... more

Musculoskeletal Stocks Outperforming Broader Markets During Financial Crisis BY MATT LOESCH, OCTOBER 6, 2008

Musculoskeletal stocks have performed relatively well year to date only down 14% compared to the S&P 500, which is down 25%. Despite financial uncertainty roiling the market on what seems like a daily basis, musculoskeletal stocks have displayed resiliency to... more

GAO Report Could Shake Up the 510(k) Process BY LAUREN UZDIENSKI, OCTOBER 6, 2008

The 510(k) clearance process as we know it - roughly 90 days of FDA review time and minimal data requirements - could become more burdensome in the next few years as the FDA responds to what's widely expected to be... more

Musculoskeletal News Roundup 2-Oct-08 BY LAUREN UZDIENSKI, OCTOBER 2, 2008

M&A Arthro Kinetics announced that they are pursuing a potential asset sale. The company said this week that their current $5.0 million cash balance was not sufficient to sustain operations. Tecomet has been acquired from Cardinal Health by Charlesbank Capital... more

Orthopedic Venture Capital Down but not Out BY JOHN MCCORMICK, OCTOBER 2, 2008

What do the severe dislocations seen in the credit markets mean for the orthopedic device startup looking for venture capital? Duly noting we are not a venture capital firm (we perform buyouts), our observation from afar is that the venture... more

Orthofix Credit Deal: A Litmus Test of the Times BY JOHN MCCORMICK, OCTOBER 1, 2008

Even in these troubled markets, there is a price for everything. On Monday, in the midst of one of the greatest credit dislocations in history, Orthofix announced that it has amended its existing credit facility. In an even more remarkable... more


Complete Archive